Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity

ARAZ-ERSAN, Bilge; Kir, Nur; Tuncer, Samuray; Aydinoglu-Candan, Ozlem; Yildiz-Inec, Dilbade; Akdogan, Basri; Ekici, Baris; Demirel, Atalay; Ozmen, Meral

doi:10.3109/02713683.2014.941070

Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity

Copy For Citation

ARAZ-ERSAN B., Kir N., Tuncer S., Aydinoglu-Candan O., Yildiz-Inec D., Akdogan B., ...More

CURRENT EYE RESEARCH, vol.40, no.6, pp.585-591, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 40 Issue: 6
Publication Date: 2015
Doi Number: 10.3109/02713683.2014.941070
Journal Name: CURRENT EYE RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.585-591
Keywords: Antivascular endothelial growth factor, bevacizumab, retinopathy of prematurity, ENDOTHELIAL GROWTH-FACTOR, INJECTION, SAFETY, AVASTIN, BAYLEY, CHILD, ROP
Istanbul University Affiliated: Yes

Abstract

Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment.